19-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Genome Editing Market Technology (CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Transcriptor-Activator-Like Effector Nuclease), ZFN (Zinc Finger Nucleases), Antisense, Others), By Application (Cell Line Engineering, Genetic Engineering, and Others), and End-User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Genome Editing market in 2019 was approximately USD 4,000.00 Million. The market is expected to grow at a CAGR of around 15.0% and is anticipated to reach around USD 9,500.00 Million by 2026.
Genome editing or gene editing is a technology used to change an organism’s DNA sequence. Using genome editing technology, one can add, delete or alter an organism’s DNA at a particular location. An enzyme typically nuclease is used to cut the DNA at a specific sequence. After the cut is made with the nuclease enzyme, the cell will repair the DNA using its own repair mechanism. Various tools are used for genome editing which includes CRISPRCas9, TALEN, antisense technology, etc. Genome editing tool has become of prime importance owing to its applications in genetic engineering such as the production of transgenic animals, targeted gene mutation, gene function study using stem cells, gene therapy for various diseases, targeted transgene addition, gene labeling, etc.
Browse the full “Genome Editing Market Technology (CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Transcriptor-Activator-Like Effector Nuclease), ZFN (Zinc Finger Nucleases), Antisense, Others), By Application (Cell Line Engineering, Genetic Engineering, and Others), and End-User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/genome-editing-market-technology-crispr-clustered-regularly-interspaced-816
Increasing the number of application areas such as gene therapy for treating diseases in humans, genetic breeding in animals and plants to improve efficiency, the productivity of livestock or crop yield, improve stress tolerance, trait improvement, production of biopharmaceuticals, is the key factor in the increasing importance of genome editing. Thus, growing application areas of genomics drive the demand for genome editing market. Rising government funding and growth in the number of genomics projects are the key factors fueling the growth of the global genome editing market.
The global genome editing market is expected to grow owing to the in-demand by increasing an extensive focus on research and development by key players. However, the lack of skilled professionals, the huge cost of the procedure and ethical concerns associated with genome editing may hamper the market’s growth. Innovations activities, research, and development, in the technology of genome editing and increased government investment in healthcare industries, are anticipated to open new avenues for the genome editing market in the near future.
On the basis of technology, the global genome editing market is segmented as CRISPR (clustered regularly interspaced short palindromic repeats), TALEN (transcriptor-activator-like effector nuclease), ZFN (zinc finger nucleases), antisense, others. Among which CRISPR (clustered regularly interspaced short palindromic repeats) segment was accounted for the major revenue share in the global genome editing market in 2019. The innovation in the CRISPR (clustered regularly interspaced short palindromic repeats) in recent years is expected to positively impact segment growth. In 2019, the CRISPR (clustered regularly interspaced short palindromic repeats) segment was accounted for more than 30.0% of the global genome editing industries.
In terms of application, the worldwide genome editing market is categorized into genetic engineering, cell-line engineering, and others. Among the above-mentioned segment, the cell-line engineering segment was accounted for over 40.0% revenue share in 2019. Increasing investment from private and government organizations expanding industry focus on stem cell research about stem cell therapies are fueling the growth of this cell-line engineering segment.
On the basis of the end-user, the global genome editing market is categorized into pharmaceutical and biotechnological companies, academic and research institutes, contract research organizations. Among the aforementioned segment, the pharmaceutical and biotechnological companies segment was accounted for more than 40.0% revenue share in 2019.
On the basis of region the genome editing market is segmented into, Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. In 2019, the North American region dominates the genome editing market among all the regions followed by Europe in terms of value.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 4,000.00 Million |
Projected Market Size in 2026 |
USD 9,500.00 Million |
CAGR Growth Rate |
15.0% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
NTransposagen Biopharmaceuticals, Thermo Fisher Scientific, Editas Medicine, HorizonDiscovery, Integrated DNA Technologies, GenScript, Lonza Group, OriGene Technologies, SangamoBioSciences, Intellia Therapeutics, Merck, CRISPR Therapeutics and precision BioSciences, and Others |
Key Segment |
By Technology, Application, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
Some of the key players operating in the market include
Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Editas Medicine, HorizonDiscovery, Integrated DNA Technologies, GenScript, Lonza Group, OriGene Technologies, SangamoBioSciences, Intellia Therapeutics, Merck, CRISPR Therapeutics and precision BioSciences, among others.
This report segments the global genome editing market as follows:
By Technology Analysis
- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
- TALEN (Transcriptor-Activator-Like Effector Nuclease)
- ZFN (Zinc Finger Nucleases)
- Antisense
- Others
By Application Analysis
- Cell Line Engineering
- Genetic Engineering
- Others
By End-User Analysis
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Contract Research Organizations
By Regional Analysis
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
